Drugs / Rocuronium
Rocuronium
also known as
Rocuronium Bromide · Esmeron · Zemuron · rocuronium: Esmeron · Zemuron Injection (rocuronium bromide) · Bromure de rocuronium · Bromuro de rocuronio · Org 9426 · +7 more
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | ZEMURON | — | 2008-08-28 | fda.gov ↗ |
| Approved | US (FDA) | ZEMURON | — | 1994-03-17 | fda.gov ↗ |
Trials 115 · started per year
today
US approved 1994
3
4
1
2
1
4
3
9
5
11
13
11
9
8
8
5
4
3
4
1
3
3
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT05619848 | Oct → Dec 2022 | lumbar spinal stenosis | Zheng Guo | Completed | No outcome recorded |
| Phase 0 | NCT05097508 | Jun 2020 → Jun 2021 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 27 trials · 2 missed | ||||||
| Phase 2 | NCT07252921 | Oct → Dec 2025 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT03808077 | Jan 2019 → Oct 2024 overdue | prostate cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
| Phase 2 | NCT03532178 | Jan 2019 → Mar 2022 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 2 | NCT02790164 | May → Nov 2016 | cardiac arrest | Chun Song Youn | Completed | No outcome recorded |
| Phase 2 | NCT02260258 | Oct 2014 → May 2019 | cardiac arrest | Beth Israel Deaconess Medical Center | Completed | Missed primary |
| Phase 2 | NCT01571908 | Sep 2012 → Jul 2015 | — | University Hospital, Geneva | Completed | Missed primary |
| Phase 2 | NCT03519867 | Aug 2004 → May 2005 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 313 trials · 2 met primary · 1 missed | ||||||
| Phase 3 | NCT05725031 | Apr 2023 → Feb 2024 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT04709315 | Oct 2020 → Jan 2021 | — | South Valley University | Unknown | No outcome recorded |
| Phase 3 | NCT03043157 | Feb → Mar 2017 | — | Brasilia University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02000674 | Dec 2013 → Jul 2016 | — | Centre Hospitalier Universitaire de la Réunion | Completed | Missed primary |
| Phase 3 | NCT00656799 | Apr 2008 → Jul 2009 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00559468 | Dec 2006 → Mar 2007 | — | Merck Sharp & Dohme LLC | Completed | Met primary |
| Phase 3 | NCT00474253 | Feb → Aug 2006 | — | Merck Sharp & Dohme LLC | Completed | Met primary |
| Phase 3 | NCT00421148 | May 2005 → May 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00124722 | Dec 2004 → Jul 2007 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00124735 | Oct 2004 → Aug 2007 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00984633 | Jun → Dec 2003 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00988520 | May → Sep 2003 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00970762 | Feb 2003 → Feb 2004 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 441 trials · 7 met primary · 3 missed | ||||||
| Phase 4 | NCT07650552 | Sep 2026 → Aug 2028 expected | apnea of prematurity, newborn respiratory distress syndrome, pulmonary immaturity | UEA - Universidade Do Estado Do Amazonas | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07168252 | Dec 2025 → Dec 2026 expected | — | Clare Hayes-Bradley | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06029049 | Sep 2023 → Jun 2025 overdue | — | The University of Texas Health Science Center, Houston | Recruiting | No outcome recorded |
| Phase 4 | NCT05562999 | Nov 2022 → Aug 2024 | — | Radboud University Medical Center | Completed | Missed primary |
| Phase 4 | NCT05509192 | Aug 2022 → Jan 2025 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT03643913 | Dec 2018 → Nov 2024 | arthropathy | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
| Phase 4 | NCT03608436 | Oct 2018 → Mar 2021 | — | Radboud University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03572413 | Oct 2018 → Aug 2020 | — | Radboud University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03646266 | Aug 2018 → Dec 2020 | respiratory failure | Amsterdam UMC, location VUmc | Unknown | No outcome recorded |
| Phase 4 | NCT03543826 | May → Nov 2018 | myopathy | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT03031808 | Oct 2017 → Dec 2020 | — | Ostfold Hospital Trust | Unknown | No outcome recorded |
| Phase 4 | NCT03170661 | Jun 2017 → Apr 2020 | — | Leiden University Medical Center | Completed | Missed primary |
| Phase 4 | NCT03039543 | Jun → Nov 2017 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03060707 | Mar → Nov 2017 | — | Seoul National University Hospital | Unknown | Met primary |
| Phase 4 | NCT02812186 | Dec 2016 → Jan 2019 | cholecystitis, chronic kidney disease, endometriosis, intestinal obstruction +3 | Stony Brook University | Completed | Met primary |
| Phase 4 | NCT02778945 | Sep 2016 → Mar 2019 | myopathy, vertebral column disorder | The Catholic University of Korea | Unknown | No outcome recorded |
| Phase 4 | NCT02484651 | Sep 2016 → Jun 2017 | neuromuscular disease | Centro Hospitalar do Porto | Completed | Mixed |
| Phase 4 | NCT02451202 | Jun 2016 → Mar 2018 | — | Chulalongkorn University | Completed | No outcome recorded |
| Phase 4 | NCT02724111 | May 2016 → Feb 2017 | vertebral column disorder | Korea University Guro Hospital | Completed | Met primary |
| Phase 4 | NCT02703909 | May 2016 → May 2017 | morbid obesity | University of Missouri-Columbia | Completed | No outcome recorded |
| Phase 4 | NCT02589691 | Dec 2015 → Dec 2024 | — | Fondation Ophtalmologique Adolphe de Rothschild | Unknown | No outcome recorded |
| Phase 4 | NCT02553629 | Sep 2015 → Apr 2016 | — | Leiden University Medical Center | Completed | Met primary |
| Phase 4 | NCT02513693 | Jul 2015 → Mar 2016 | — | Palacky University | Unknown | No outcome recorded |
| Phase 4 | NCT02467595 | Jul 2015 → Oct 2016 | — | Korea University Anam Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02410590 | Jul 2015 → Oct 2016 | — | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded |
| Phase 4 | NCT02194855 | Jan 2015 → Jan 2016 | — | Fudan University | Completed | No outcome recorded |
| Phase 4 | NCT01941628 | Aug 2014 → Dec 2016 | — | Charles University, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT02237443 | Aug → Nov 2014 | — | University of Washington | Completed | Met primary |
| Phase 4 | NCT02118844 | Jul 2014 → Aug 2015 | morbid obesity | Central Hospital, Nancy, France | Unknown | Met primary |
| Phase 4 | NCT02399397 | Feb 2014 → Dec 2015 | autoinflammatory syndrome, infectious disease with sepsis | São Paulo State University | Completed | No outcome recorded |
| Phase 4 | NCT02004015 | Nov 2013 → Apr 2015 | — | Fondation Ophtalmologique Adolphe de Rothschild | Terminated | No outcome recorded |
| Phase 4 | NCT01930747 | Apr 2013 → Dec 2015 | — | AZ Sint-Jan AV | Completed | No outcome recorded |
| Phase 4 | NCT01748643 | Apr 2013 → Jan 2015 | obesity disorder | Ziekenhuis Oost-Limburg | Completed | Missed primary |
| Phase 4 | NCT01728584 | Nov 2012 → Apr 2014 | gallbladder disorder | Merck Sharp & Dohme LLC | Completed | Met primary |
| Phase 4 | NCT01718236 | Sep 2012 → Jan 2015 | pregnancy disorder | Brno University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01651572 | Jul 2012 → Jul 2013 | curariform drugs toxicity | Azienda Ospedaliera di Padova | Completed | No outcome recorded |
| Phase 4 | NCT01804933 | Jul 2012 → Jul 2013 | — | Ying Xiao | Unknown | No outcome recorded |
| Phase 4 | NCT01579864 | Jan 2012 → Jun 2015 | — | Hopital Foch | Terminated | No outcome recorded |
| Phase 4 | NCT00953550 | Sep 2009 → Jan 2011 | — | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT01142635 | Apr 2009 → Mar 2010 | — | Tampere University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02785653 | Apr 2004 → Nov 2006 | — | Maharashtra University of Health Sciences | Completed | No outcome recorded |
| Phase not applicable52 trials · 2 met primary · 3 missed | ||||||
| — | NCT07627750 | Jun 2026 → Dec 2028 expected | — | Bach Mai Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07464288 | Mar → Apr 2026 overdue | — | Ankara City Hospital Bilkent | Not yet recruiting | No outcome recorded |
| — | NCT07035301 | Mar → Jul 2025 | respiratory system disorder | Harbin Medical University | Completed | No outcome recorded |
| — | NCT06553066 | Aug 2024 → Aug 2026 overdue | — | University Hospital of Patras | Not yet recruiting | No outcome recorded |
| — | NCT05909696 | Jul → Oct 2023 | curariform drugs toxicity | Yangzhou University | Completed | No outcome recorded |
| — | NCT05279898 | Feb 2023 → Jun 2024 | delirium | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| — | NCT05453929 | Sep 2021 → Dec 2024 | vertebral column disorder | Korea University Guro Hospital | Completed | No outcome recorded |
| — | NCT04924621 | Jun 2021 → May 2022 | substance withdrawal syndrome | Peking University | Unknown | No outcome recorded |
| — | NCT04821817 | Apr 2021 → Feb 2025 | strabismus | Tanta University | Completed | No outcome recorded |
| — | NCT04768400 | Mar 2021 → May 2022 | brain neoplasm | Gangnam Severance Hospital | Completed | No outcome recorded |
| — | NCT05689957 | Dec 2020 → Dec 2021 | female reproductive system disorder | Universiti Sains Malaysia | Completed | No outcome recorded |
| — | NCT04259112 | Oct 2020 → Oct 2023 | acute kidney injury, diabetes mellitus | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| — | NCT03441828 | Feb → Jul 2020 | — | Federico II University | Completed | Met primary |
| — | NCT03937440 | Jul → Dec 2019 | gastric cancer | Yonsei University | Completed | No outcome recorded |
| — | NCT03287388 | May → Nov 2019 | neuromuscular disease | Radboud University Medical Center | Unknown | No outcome recorded |
| — | NCT03890406 | Apr → Dec 2019 | — | Seoul National University Bundang Hospital | Completed | Missed primary |
| — | NCT03871387 | Mar 2019 → Feb 2020 | thyroid tumor | Yonsei University | Completed | No outcome recorded |
| — | NCT03830086 | Feb → Apr 2019 | — | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Completed | No outcome recorded |
| — | NCT03782233 | Jan → Jul 2019 | — | The First Affiliated Hospital with Nanjing Medical University | Completed | No outcome recorded |
| — | NCT03726372 | Nov 2018 → Nov 2019 | — | Air Force Military Medical University, China | Unknown | No outcome recorded |
| — | NCT03576118 | Nov 2018 → Jul 2019 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| — | NCT03266419 | Mar → Nov 2018 | — | Asan Medical Center | Completed | Missed primary |
| — | NCT03299621 | Nov 2017 → Aug 2018 | — | Korea University Anam Hospital | Unknown | No outcome recorded |
| — | NCT03270696 | Aug 2017 → Jan 2018 | — | Seoul National University Hospital | Completed | Met primary |
| — | NCT03391700 | Aug 2017 → Jul 2018 | pharyngitis | SMG-SNU Boramae Medical Center | Unknown | No outcome recorded |
| — | NCT03424356 | Jan 2017 → Dec 2018 | — | TC Erciyes University | Unknown | No outcome recorded |
| — | NCT02762890 | Oct 2016 → Feb 2017 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02827435 | Jul 2016 → Jul 2019 | disease related to solid organ transplantation, end stage renal failure | Seoul National University Hospital | Unknown | No outcome recorded |
| — | NCT03318718 | Feb 2016 → Dec 2018 | — | Balgrist University Hospital | Completed | No outcome recorded |
| — | NCT02657187 | Feb → Jul 2016 | — | Go Eun Bae | Unknown | No outcome recorded |
| — | NCT02546843 | Dec 2015 → Sep 2018 | — | Brno University Hospital | Completed | No outcome recorded |
| — | NCT04236050 | Dec 2015 → Aug 2017 | lumbar disk disease | Clinical Hospital Centre Zagreb | Completed | No outcome recorded |
| — | NCT02601508 | Nov 2015 → Aug 2016 | — | Chonnam National University Hospital | Unknown | No outcome recorded |
| — | NCT02575443 | Sep 2015 → Sep 2017 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT02711917 | Jul → Dec 2015 | — | Tianjin Medical University General Hospital | Completed | No outcome recorded |
| — | NCT02400931 | Apr → Nov 2015 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02471521 | Feb → Dec 2015 | — | Seoul National University Hospital | Completed | Missed primary |
| — | NCT02249585 | Sep 2014 → Oct 2016 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02266056 | Aug 2014 → Sep 2015 | colorectal cancer | Yonsei University | Completed | No outcome recorded |
| — | NCT02109133 | May → Dec 2014 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02495038 | Mar 2014 → Feb 2015 | chronic otitis media | Yonsei University | Completed | No outcome recorded |
| — | NCT02064140 | Feb → Nov 2014 | acute respiratory distress syndrome | University Medical Center Nijmegen | Completed | No outcome recorded |
| — | NCT02025075 | Jan 2014 → Oct 2015 | acute lung injury | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01849211 | Apr 2013 → Apr 2017 | — | Kreiskrankenhaus Dormagen | Completed | No outcome recorded |
| — | NCT01672606 | May 2012 → Feb 2016 | obstructive sleep apnea syndrome | Malin Jonsson Fagerlund | Completed | No outcome recorded |
| — | NCT01564576 | Apr → Aug 2012 | morbid obesity | Sheba Medical Center | Unknown | No outcome recorded |
| — | NCT02054468 | Mar 2012 → Feb 2014 | — | Technical University of Munich | Completed | No outcome recorded |
| — | NCT01479751 | Nov 2011 → May 2012 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT01441960 | May 2011 → Jul 2013 | — | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01532466 | Mar → Oct 2011 | — | Taichung Armed Forces General Hospital | Completed | No outcome recorded |
| — | NCT04035707 | Jun 2009 → Jun 2010 | hypersensitivity reaction disease | Medical University of Bialystok | Completed | No outcome recorded |
| — | NCT00926718 | Jun 2009 → Jun 2010 | laryngostenosis | St. Vincent's Medical Center | Unknown | No outcome recorded |
| Comparator or background therapy183 trials | ||||||
| Phase 0 | NCT06720285 Background | Oct → Nov 2023 | — | Universitas Airlangga | Completed | No outcome recorded |
| Phase 0 | NCT05294926 Comparator | Apr 2022 → Jan 2023 | — | Assiut University | Unknown | No outcome recorded |
| Phase 0 | NCT04016740 Background | Aug 2019 → Feb 2020 | coronary artery disorder, delirium | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT07603596 Background | May 2026 → Apr 2028 expected | delirium, digestive system neoplasm | Qianfoshan Hospital | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT02888067 Comparator | Jul 2017 → Jul 2022 | — | Thomas Schricker | Terminated | No outcome recorded Stop: Enrollment |
| Show all 183 trials opens the full record — a long page | ||||||
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2023-03-20 | Lupin Limited | Regulatory Lupin’s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium Bromide Injection lupin.com ↗ |
All press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-11-08 | Lupin Limited | Lupin Launches Rocuronium Bromide Injection in the United States lupin.com ↗ |
| 2023-03-20 | Lupin Limited | Lupin’s Alliance Partner Caplin Receives U.S. FDA Approval for Rocuronium Bromide Injection lupin.com ↗ |
| 2015-12-17 | Merck Sharp & Dohme LLC | Merck’s BRIDION® (sugammadex) Receives FDA Approval for the Reversal of Neuromuscular Blockade Induced by Rocuronium and Vecuronium in Adults Undergoing Surgery merck.com ↗ |
| 2015-11-06 | Merck Sharp & Dohme LLC | Merck Statement on FDA Advisory Committee Meeting for BRIDION® (sugammadex), Investigational Agent for the Reversal of Neuromuscular Blockade (NMB) Induced by Rocuronium or Vecuronium merck.com ↗ |
Evidence & citations 19 cited values
Every value below carries the sentence it was read from. 301 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rocuronium | “Rocuronium and cisatracurium are representative neuromuscular blocking agents used widely because the former have features of fast onset of peak effect and short duration of...” NCT02495038 ↗269“When participants reach the titration endpoint (OAAS score 1 point) during the titration of propofol in the induction, the investigators stop the dosing and switch to a...” NCT04595591 ↗ “Maintenance of anesthesia will be achieved by isoflurane at an end tidal concentration of 1-1.5% in FiO2 of 0.5, intravenous fentanyl at a dose of 1 µg/kg in incremental...” NCT06873906 ↗ “1-3 mg IV propofol 0.5 mg/kg IV Rocuronium + Fentanyl 2-3 mcg/kg + Morphine 0.1mg/kg IV Maintenance: Volatile anesthetic + High volume local anesthesia infiltration Bupivacaine...” NCT03176758 ↗ “The investigators therefore hypothesized that remifentanil could prolong the onset time of rocuronium, and evaluated the effect of remifentanil on the hemodynamic profiles...” NCT01030510 ↗ “Anesthetized patients (American Society of Anesthesiologists class 1-2) received 0.6 mg/kg rocuronium and were randomized to receive sugammadex (0.5, 1.0, 2.0, or 4.0 mg/kg) or...” PMID 19194156 ↗ Feb 2009 “Remimazolam 6mg/kg/h was pumped intravenously for 2.5 min, Sufentanil 0.5 μg/kg and rocuronium 0.6mg/kg were injected intravenously, and endotracheal intubation was performed 3...” NCT06775366 ↗ “Midazolam 0.03 mg/kg injection vein，Sufentanyl 0.5\~1 μg/kg, target controlled infusion of etomidate or propofol,after the consciousness of patients is lost, rocuronium...” NCT02644980 ↗ “Deep neuromuscular block will be induced by rocuronium bolus 1 mg/kg, maintained by a continuous infusion of rocuronium (0.6mg/kg/h), and titrated towards post-tetanic count (PTC) 1-2.” NCT04259112 ↗ “In addition to propofol as a hypnotic and rocuronium as a muscle relaxant, patients in the conventional opioid-based group will receive the following drugs: Remifentanil and Fentanyl” NCT05485480 ↗ “General anesthesia will be induced with fentanyl 1,5 mcg/kg, propofol 2 mg/kg, rocuronium 0,6 mg/kg; after intubation anesthesia will be mantained with sevoflurane (MAC 1).” NCT04294537 ↗ |
| Known as | Bromure de rocuronium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Bromuro de rocuronio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Esmeron | “Drug: Rocuronium Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h Other Name: Esmeron” NCT01722097 ↗8“During the ablation performed, the patient will be under the influence of a muscle relaxant from the non-depolarising group (rocuronium, Esmeron®).” NCT06707532 ↗ “In this case the use of another neuromuscular blockade, Rocuronium (ESMERON), is an alternative solution.” NCT03960801 ↗ “rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576 ↗ “0.6 mg/kg Rocuronium bromide (esmeron)” NCT06399445 ↗ “Rocuronium (Esmeron):” NCT01651572 ↗ |
| Known as | Org 9426 | “Rocuronium bromide (Org 9426)” NCT00984633 ↗ |
| Known as | ROC | “This study aims to evaluate the influence of age and sepsis on in vivo activity of OATP1A2 using rocuronium (ROC) as a probe and evaluating the pharmacokinetics and...” NCT02399397 ↗ |
| Known as | Rocnium | “Continuous Rocuronium (Rocnium®, Hanlim Pharm. Co., Ltd., South Korea) infusion during surgery” NCT03871387 ↗ |
| Known as | rocunium | “Deep neuromuscular block with 'rocunium®'” NCT03937440 ↗ |
| Known as | Rocuronium Bromide | “BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an...” PMID 33337797 ↗ Dec 202133“Induction of anesthesia will be the same for all patients and consist of intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle...” NCT05958589 ↗ “To achieve NMB, participants received steroidal NMBA Rocuronium Bromide or Vecuronium Bromide administered via i.v. infusion and dosed according to participant ABW.” NCT03346070 ↗ “participants received steroidal NMBA Rocuronium Bromide administered via IV infusion and dosed according to participant body weight.” NCT03346057 ↗ “Propofol, Atracurium Besilate or Cisatracurium besylate or Rocuronium Bromide” NCT04553536 ↗ “Rocuronium Bromide (Pretreatment Injection)” NCT07716891 ↗ “rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576 ↗ “Rocuronium bromide” NCT04760912 ↗ “Rocuronium Bromide” NCT05687253 ↗ “Rocuronium bromide” NCT01142635 ↗ |
| Known as | Rocuronium bromide: Zemuron | “Rocuronium bromide: Zemuron” NCT01450813 ↗ |
| Known as | Rocuronium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Rocuronium Injectable Solution | “Drug: Rocuronium Injectable Solution” NCT02953210 ↗ |
| Known as | Rocuronium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | rocuronium: Esmeron | “rocuronium: Esmeron” NCT01748643 ↗1“Rocuronium, Esmeron” NCT02794714 ↗ |
| Known as | Zemuron | “Rocuronium: Zemuron. Sugammadex: Bridion. Succinylcholine: Suxamethonium” NCT03532178 ↗ |
| Known as | Zemuron Injection (rocuronium bromide) | “Zemuron® Injection (rocuronium bromide)” NCT00751179 ↗1“Zemuron® Injection (rocuronium bromide)” NCT01728584 ↗ |
| Action | Inhibit | “By binding free rocuronium, less rocuronium becomes available at the neuromuscular junction to bind to the muscarine receptor. Non-depolarizing neuromuscular blocking agents...” NCT01631149 ↗ |
| Modality | Other / unclassified | “two commonly used neuromuscular blocking agents (succinylcholine and rocuronium)” NCT01441960 ↗ |
| Route | Intravenous | “A single IV Zemuron bolus dose of 0.45 mg/kg prior to intubation.” NCT00124722 ↗ |